Short Bowel Syndrome (SBS)
Gastroenterology·MeSH: Short Bowel Syndrome
Prevalence
5.0 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| vurolenatide | 9 METERS BIOPHARMA, INC. (NMTR) |
Frequently asked questions
How many drugs are in development for Short Bowel Syndrome (SBS)?
BioSniper tracks 1 drug in development for Short Bowel Syndrome (SBS) across 1 company.
How many clinical trials target Short Bowel Syndrome (SBS)?
There are 3 clinical trials targeting Short Bowel Syndrome (SBS) tracked by BioSniper.
What is the prevalence of Short Bowel Syndrome (SBS)?
The estimated prevalence of Short Bowel Syndrome (SBS) is approximately 5.0 per 100,000 population.
Deep-dive into Short Bowel Syndrome (SBS)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis